Jones Trading Initiates Coverage On Azora Therapeutics with Buy Rating, Announces Price Target of $14
Benzinga Newsdesk 8 hours ago
Analyst RatingsNewsInitiationPrice Target
Jones Trading analyst Debanjana Chatterjee initiates coverage on Azora Therapeutics (NASDAQ:AZR) with a Buy rating and announces Price Target of $14.
Jones Trading analyst Debanjana Chatterjee initiates coverage on Azora Therapeutics (NASDAQ:AZR) with a Buy rating and announces Price Target of $14.